Showing results (4801-4810 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 20, 2025
Steroid-refractory immune mediated hepatitis managed with budesonide in patients with metastatic melanoma: proof of concept and literature reviewRoma A Kankaria, Douglas B Johnson
The Oncologist|March 26, 2025
Prophylaxis, clinical management, and monitoring of datopotamab deruxtecan-associated oral mucositis/stomatitisFunda Meric-Bernstam, Aditya Bardia, Paolo Bossi, et al.
The Oncologist|March 5, 2025
Benefit of adjuvant chemotherapy for T1cN0M0 and selected T1bN0M0 triple-negative breast cancer: a nationwide cancer registry-based studyChiao Lo, Dwan-Ying Chang, Yen-Shen Lu, et al.
The Oncologist|November 28, 2024
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort studyCarmine Valenza, Eleonora Nicolò, Marta Mongillo, et al.
The Oncologist|December 24, 2024
The lifecycle and evolution of new regimens on the National Comprehensive Cancer Network Guidelines for newly diagnosed multiple myelomaGhulam Rehman Mohyuddin, Jehad Almasri, Aaron Goodman, et al.
The Oncologist|December 20, 2024
Supporting patients with advanced cancer and their spouses in parenting minor children: results of a randomized controlled trialKathrin Milbury, Sujin Ann-Yi, Meagan S Whisenant, et al.
The Oncologist|December 10, 2024
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancerHoward J Lee, John Boscardin, Louise C Walter, et al.
The Oncologist|December 14, 2024
Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analysesFrancesco Schettini, Estela Pineda, Andrea Rocca, et al.
The Oncologist|December 14, 2024
Second-line therapies in advanced hepatocellular carcinoma following first-line atezolizumab and bevacizumab: multicenter single institution cohort experiencePaulina Marell, Ioannis Kournoutas, Jennifer Gile, et al.
The Oncologist|December 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO studyJavier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado, et al.
Pageof 571